The brokerage firm Motilal Oswal had a ‘Buy call on three stocks on March 11. It has picked Sun Pharma after Checkpoint ...

Sun Pharma surges 3% on Checkpoint Therapeutics acquisition; Motilal Oswal maintains 'Buy' with 22% upside potential. Read ...

India Business Excellence Fund IV (via MO Alternate Investment Advisors) and Motilal Oswal Finvest—have acquired over 60% of ...

MUMBAI: Financial services giant Motilal Oswal has promoted Varun Mundra to group head of media and innovations, capping the ...

Motilal Oswal Financial Services has promoted Varun Mundra to group head– media and innovations. Before this, Mundra served as senior vice president of marketing at Motilal Oswal Financial Services.

Motilal Oswal Financial Services estimated a 23% Ebitda CAGR for Bharti Hexacom for the period from financial year 2024 to ...

Motilal Oswal initiated coverage on Bharti Hexacom with a ‘buy’ rating and Rs 1,625 target, citing strong growth potential in ...

Nuvama has downgraded IndusInd Bank to "Reduce" citing concerns over internal derivative trades and management changes, while ...

Motilal Oswal has initiated coverage on Bharti Hexacom with a Buy rating, emphasizing its growth potential due to lower ...

As Holi 2025 approaches, investors are looking for vibrant opportunities in the stock market to add long-term wealth to their ...

Jayesh Faria from Motilal Oswal predicts the Indian stock market will remain flat to negative for a few months. He advises ...

Motilal Oswal remains optimistic about Bharti Hexacom, which has surged over 136% since its April 2024 listing. The brokerage ...